/PRNewswire/ After twenty years as one of the first personalized oncology companies, Indivumed today announced its evolution into Indivumed Therapeutics.
Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, announced today that it has completed its acquisition of the IndivuServ business unit of Indivumed GmbH